PAION AG is a publicly listed specialty pharmaceutical company with innovative drugs to be used in hospital-based sedation, anesthesia and critical care services. 

 

Learn more About PAION

Our Mission

PAION’s mission is to be a leading specialty pharmaceutical company in the fields of anesthesia and critical care by bringing novel products to market to benefit patients, doctors and other stakeholders in healthcare. 

PAION's Strategy & Partnering

H1 2021

Teleconference & webcast

23. August 2021

Replay

news

09/16/2021

PAION AG ANNOUNCES INITIATION OF PIVOTAL STUDY OF REMIMAZOLAM (BYFAVO(R)) IN...

DGAP-News: PAION AG / Key word(s): Study 16.09.2021 / 14:00 The...

Read more
09/02/2021

PAION SIGNS EXCLUSIVE UK SUPPLY AND DISTRIBUTION AGREEMENT WITH CLINIGEN

DGAP-News: PAION AG / Key word(s): Miscellaneous 02.09.2021 /...

Read more
09/01/2021

PAION LAUNCHES XERAVA(R) (ERAVACYCLINE) FOR THE TREATMENT OF COMPLICATED...

DGAP-News: PAION AG / Key word(s): Market launch 01.09.2021 /...

Read more

PAION Chart

Load Chart

I consent to the display of external content. This enables personal data to be transmitted to third-party platforms. Read more about our privacy policy.